Global Cellular and Gene Therapy CDMO Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Cellular and Gene Therapy CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cellular and Gene Therapy CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cellular and Gene Therapy CDMO market in any manner.
Global Cellular and Gene Therapy CDMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Catalent
Lonza
Charles River
The Discovery Labs
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith
ThermoGenesis
Anemocyte
Thermo Fisher Scientific
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio
Oxford BioMedica
Porton Pharma Solutions
Market Segmentation (by Type)
Cell Therapy
Viral Vectors
Plasmid
Market Segmentation (by Application)
Commercial
Academic Research
Others
Geographic Segmentation
%li%North America (USA, Canada, Mexico)
%li%Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
%li%Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
%li%South America (Brazil, Argentina, Columbia, Rest of South America)
%li%The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
%li%Industry drivers, restraints, and opportunities covered in the study
%li%Neutral perspective on the market performance
%li%Recent industry trends and developments
%li%Competitive landscape & strategies of key players
%li%Potential & niche segments and regions exhibiting promising growth covered
%li%Historical, current, and projected market size, in terms of value
%li%In-depth analysis of the Cellular and Gene Therapy CDMO Market
%li%Overview of the regional outlook of the Cellular and Gene Therapy CDMO Market:
Key Reasons to Buy this Report:
%li%Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
%li%This enables you to anticipate market changes to remain ahead of your competitors
%li%You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
%li%The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
%li%Provision of market value (USD Billion) data for each segment and sub-segment
%li%Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
%li%Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
%li%Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
%li%Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
%li%The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
%li%Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
%li%Provides insight into the market through Value Chain
%li%Market dynamics scenario, along with growth opportunities of the market in the years to come
%li%6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cellular and Gene Therapy CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Cellular and Gene Therapy CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cellular and Gene Therapy CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cellular and Gene Therapy CDMO market in any manner.
Global Cellular and Gene Therapy CDMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Catalent
Lonza
Charles River
The Discovery Labs
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith
ThermoGenesis
Anemocyte
Thermo Fisher Scientific
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio
Oxford BioMedica
Porton Pharma Solutions
Market Segmentation (by Type)
Cell Therapy
Viral Vectors
Plasmid
Market Segmentation (by Application)
Commercial
Academic Research
Others
Geographic Segmentation
%li%North America (USA, Canada, Mexico)
%li%Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
%li%Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
%li%South America (Brazil, Argentina, Columbia, Rest of South America)
%li%The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
%li%Industry drivers, restraints, and opportunities covered in the study
%li%Neutral perspective on the market performance
%li%Recent industry trends and developments
%li%Competitive landscape & strategies of key players
%li%Potential & niche segments and regions exhibiting promising growth covered
%li%Historical, current, and projected market size, in terms of value
%li%In-depth analysis of the Cellular and Gene Therapy CDMO Market
%li%Overview of the regional outlook of the Cellular and Gene Therapy CDMO Market:
Key Reasons to Buy this Report:
%li%Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
%li%This enables you to anticipate market changes to remain ahead of your competitors
%li%You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
%li%The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
%li%Provision of market value (USD Billion) data for each segment and sub-segment
%li%Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
%li%Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
%li%Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
%li%Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
%li%The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
%li%Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
%li%Provides insight into the market through Value Chain
%li%Market dynamics scenario, along with growth opportunities of the market in the years to come
%li%6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cellular and Gene Therapy CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cellular and Gene Therapy CDMO
1.2 Key Market Segments
1.2.1 Cellular and Gene Therapy CDMO Segment by Type
1.2.2 Cellular and Gene Therapy CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELLULAR AND GENE THERAPY CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cellular and Gene Therapy CDMO Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cellular and Gene Therapy CDMO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELLULAR AND GENE THERAPY CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Global Cellular and Gene Therapy CDMO Sales by Manufacturers (2019-2024)
3.2 Global Cellular and Gene Therapy CDMO Revenue Market Share by Manufacturers (2019-2024)
3.3 Cellular and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cellular and Gene Therapy CDMO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cellular and Gene Therapy CDMO Sales Sites, Area Served, Product Type
3.6 Cellular and Gene Therapy CDMO Market Competitive Situation and Trends
3.6.1 Cellular and Gene Therapy CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cellular and Gene Therapy CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELLULAR AND GENE THERAPY CDMO INDUSTRY CHAIN ANALYSIS
4.1 Cellular and Gene Therapy CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELLULAR AND GENE THERAPY CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CELLULAR AND GENE THERAPY CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cellular and Gene Therapy CDMO Sales Market Share by Type (2019-2024)
6.3 Global Cellular and Gene Therapy CDMO Market Size Market Share by Type (2019-2024)
6.4 Global Cellular and Gene Therapy CDMO Price by Type (2019-2024)
7 CELLULAR AND GENE THERAPY CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cellular and Gene Therapy CDMO Market Sales by Application (2019-2024)
7.3 Global Cellular and Gene Therapy CDMO Market Size (M USD) by Application (2019-2024)
7.4 Global Cellular and Gene Therapy CDMO Sales Growth Rate by Application (2019-2024)
8 CELLULAR AND GENE THERAPY CDMO MARKET SEGMENTATION BY REGION
8.1 Global Cellular and Gene Therapy CDMO Sales by Region
8.1.1 Global Cellular and Gene Therapy CDMO Sales by Region
8.1.2 Global Cellular and Gene Therapy CDMO Sales Market Share by Region
8.2 North America
8.2.1 North America Cellular and Gene Therapy CDMO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cellular and Gene Therapy CDMO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cellular and Gene Therapy CDMO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cellular and Gene Therapy CDMO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cellular and Gene Therapy CDMO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Catalent
9.1.1 Catalent Cellular and Gene Therapy CDMO Basic Information
9.1.2 Catalent Cellular and Gene Therapy CDMO Product Overview
9.1.3 Catalent Cellular and Gene Therapy CDMO Product Market Performance
9.1.4 Catalent Business Overview
9.1.5 Catalent Cellular and Gene Therapy CDMO SWOT Analysis
9.1.6 Catalent Recent Developments
9.2 Lonza
9.2.1 Lonza Cellular and Gene Therapy CDMO Basic Information
9.2.2 Lonza Cellular and Gene Therapy CDMO Product Overview
9.2.3 Lonza Cellular and Gene Therapy CDMO Product Market Performance
9.2.4 Lonza Business Overview
9.2.5 Lonza Cellular and Gene Therapy CDMO SWOT Analysis
9.2.6 Lonza Recent Developments
9.3 Charles River
9.3.1 Charles River Cellular and Gene Therapy CDMO Basic Information
9.3.2 Charles River Cellular and Gene Therapy CDMO Product Overview
9.3.3 Charles River Cellular and Gene Therapy CDMO Product Market Performance
9.3.4 Charles River Cellular and Gene Therapy CDMO SWOT Analysis
9.3.5 Charles River Business Overview
9.3.6 Charles River Recent Developments
9.4 The Discovery Labs
9.4.1 The Discovery Labs Cellular and Gene Therapy CDMO Basic Information
9.4.2 The Discovery Labs Cellular and Gene Therapy CDMO Product Overview
9.4.3 The Discovery Labs Cellular and Gene Therapy CDMO Product Market Performance
9.4.4 The Discovery Labs Business Overview
9.4.5 The Discovery Labs Recent Developments
9.5 BIOCENTRIQ
9.5.1 BIOCENTRIQ Cellular and Gene Therapy CDMO Basic Information
9.5.2 BIOCENTRIQ Cellular and Gene Therapy CDMO Product Overview
9.5.3 BIOCENTRIQ Cellular and Gene Therapy CDMO Product Market Performance
9.5.4 BIOCENTRIQ Business Overview
9.5.5 BIOCENTRIQ Recent Developments
9.6 FUJIFILM Diosynth Biotechnologies
9.6.1 FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Basic Information
9.6.2 FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Product Overview
9.6.3 FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Product Market Performance
9.6.4 FUJIFILM Diosynth Biotechnologies Business Overview
9.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments
9.7 Exothera
9.7.1 Exothera Cellular and Gene Therapy CDMO Basic Information
9.7.2 Exothera Cellular and Gene Therapy CDMO Product Overview
9.7.3 Exothera Cellular and Gene Therapy CDMO Product Market Performance
9.7.4 Exothera Business Overview
9.7.5 Exothera Recent Developments
9.8 WuXi AppTec
9.8.1 WuXi AppTec Cellular and Gene Therapy CDMO Basic Information
9.8.2 WuXi AppTec Cellular and Gene Therapy CDMO Product Overview
9.8.3 WuXi AppTec Cellular and Gene Therapy CDMO Product Market Performance
9.8.4 WuXi AppTec Business Overview
9.8.5 WuXi AppTec Recent Developments
9.9 Pharmaron
9.9.1 Pharmaron Cellular and Gene Therapy CDMO Basic Information
9.9.2 Pharmaron Cellular and Gene Therapy CDMO Product Overview
9.9.3 Pharmaron Cellular and Gene Therapy CDMO Product Market Performance
9.9.4 Pharmaron Business Overview
9.9.5 Pharmaron Recent Developments
9.10 OBiO
9.10.1 OBiO Cellular and Gene Therapy CDMO Basic Information
9.10.2 OBiO Cellular and Gene Therapy CDMO Product Overview
9.10.3 OBiO Cellular and Gene Therapy CDMO Product Market Performance
9.10.4 OBiO Business Overview
9.10.5 OBiO Recent Developments
9.11 Cell Therapies
9.11.1 Cell Therapies Cellular and Gene Therapy CDMO Basic Information
9.11.2 Cell Therapies Cellular and Gene Therapy CDMO Product Overview
9.11.3 Cell Therapies Cellular and Gene Therapy CDMO Product Market Performance
9.11.4 Cell Therapies Business Overview
9.11.5 Cell Therapies Recent Developments
9.12 AGC Biologics
9.12.1 AGC Biologics Cellular and Gene Therapy CDMO Basic Information
9.12.2 AGC Biologics Cellular and Gene Therapy CDMO Product Overview
9.12.3 AGC Biologics Cellular and Gene Therapy CDMO Product Market Performance
9.12.4 AGC Biologics Business Overview
9.12.5 AGC Biologics Recent Developments
9.13 Cytiva
9.13.1 Cytiva Cellular and Gene Therapy CDMO Basic Information
9.13.2 Cytiva Cellular and Gene Therapy CDMO Product Overview
9.13.3 Cytiva Cellular and Gene Therapy CDMO Product Market Performance
9.13.4 Cytiva Business Overview
9.13.5 Cytiva Recent Developments
9.14 Helixmith
9.14.1 Helixmith Cellular and Gene Therapy CDMO Basic Information
9.14.2 Helixmith Cellular and Gene Therapy CDMO Product Overview
9.14.3 Helixmith Cellular and Gene Therapy CDMO Product Market Performance
9.14.4 Helixmith Business Overview
9.14.5 Helixmith Recent Developments
9.15 ThermoGenesis
9.15.1 ThermoGenesis Cellular and Gene Therapy CDMO Basic Information
9.15.2 ThermoGenesis Cellular and Gene Therapy CDMO Product Overview
9.15.3 ThermoGenesis Cellular and Gene Therapy CDMO Product Market Performance
9.15.4 ThermoGenesis Business Overview
9.15.5 ThermoGenesis Recent Developments
9.16 Anemocyte
9.16.1 Anemocyte Cellular and Gene Therapy CDMO Basic Information
9.16.2 Anemocyte Cellular and Gene Therapy CDMO Product Overview
9.16.3 Anemocyte Cellular and Gene Therapy CDMO Product Market Performance
9.16.4 Anemocyte Business Overview
9.16.5 Anemocyte Recent Developments
9.17 Thermo Fisher Scientific
9.17.1 Thermo Fisher Scientific Cellular and Gene Therapy CDMO Basic Information
9.17.2 Thermo Fisher Scientific Cellular and Gene Therapy CDMO Product Overview
9.17.3 Thermo Fisher Scientific Cellular and Gene Therapy CDMO Product Market Performance
9.17.4 Thermo Fisher Scientific Business Overview
9.17.5 Thermo Fisher Scientific Recent Developments
9.18 CBM
9.18.1 CBM Cellular and Gene Therapy CDMO Basic Information
9.18.2 CBM Cellular and Gene Therapy CDMO Product Overview
9.18.3 CBM Cellular and Gene Therapy CDMO Product Market Performance
9.18.4 CBM Business Overview
9.18.5 CBM Recent Developments
9.19 Bio Elpida
9.19.1 Bio Elpida Cellular and Gene Therapy CDMO Basic Information
9.19.2 Bio Elpida Cellular and Gene Therapy CDMO Product Overview
9.19.3 Bio Elpida Cellular and Gene Therapy CDMO Product Market Performance
9.19.4 Bio Elpida Business Overview
9.19.5 Bio Elpida Recent Developments
9.20 Genezen
9.20.1 Genezen Cellular and Gene Therapy CDMO Basic Information
9.20.2 Genezen Cellular and Gene Therapy CDMO Product Overview
9.20.3 Genezen Cellular and Gene Therapy CDMO Product Market Performance
9.20.4 Genezen Business Overview
9.20.5 Genezen Recent Developments
9.21 CCRM
9.21.1 CCRM Cellular and Gene Therapy CDMO Basic Information
9.21.2 CCRM Cellular and Gene Therapy CDMO Product Overview
9.21.3 CCRM Cellular and Gene Therapy CDMO Product Market Performance
9.21.4 CCRM Business Overview
9.21.5 CCRM Recent Developments
9.22 RoslinCT
9.22.1 RoslinCT Cellular and Gene Therapy CDMO Basic Information
9.22.2 RoslinCT Cellular and Gene Therapy CDMO Product Overview
9.22.3 RoslinCT Cellular and Gene Therapy CDMO Product Market Performance
9.22.4 RoslinCT Business Overview
9.22.5 RoslinCT Recent Developments
9.23 GenScript ProBio
9.23.1 GenScript ProBio Cellular and Gene Therapy CDMO Basic Information
9.23.2 GenScript ProBio Cellular and Gene Therapy CDMO Product Overview
9.23.3 GenScript ProBio Cellular and Gene Therapy CDMO Product Market Performance
9.23.4 GenScript ProBio Business Overview
9.23.5 GenScript ProBio Recent Developments
9.24 Oxford BioMedica
9.24.1 Oxford BioMedica Cellular and Gene Therapy CDMO Basic Information
9.24.2 Oxford BioMedica Cellular and Gene Therapy CDMO Product Overview
9.24.3 Oxford BioMedica Cellular and Gene Therapy CDMO Product Market Performance
9.24.4 Oxford BioMedica Business Overview
9.24.5 Oxford BioMedica Recent Developments
9.25 Porton Pharma Solutions
9.25.1 Porton Pharma Solutions Cellular and Gene Therapy CDMO Basic Information
9.25.2 Porton Pharma Solutions Cellular and Gene Therapy CDMO Product Overview
9.25.3 Porton Pharma Solutions Cellular and Gene Therapy CDMO Product Market Performance
9.25.4 Porton Pharma Solutions Business Overview
9.25.5 Porton Pharma Solutions Recent Developments
10 CELLULAR AND GENE THERAPY CDMO MARKET FORECAST BY REGION
10.1 Global Cellular and Gene Therapy CDMO Market Size Forecast
10.2 Global Cellular and Gene Therapy CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cellular and Gene Therapy CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Cellular and Gene Therapy CDMO Market Size Forecast by Region
10.2.4 South America Cellular and Gene Therapy CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cellular and Gene Therapy CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Cellular and Gene Therapy CDMO Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cellular and Gene Therapy CDMO by Type (2025-2030)
11.1.2 Global Cellular and Gene Therapy CDMO Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cellular and Gene Therapy CDMO by Type (2025-2030)
11.2 Global Cellular and Gene Therapy CDMO Market Forecast by Application (2025-2030)
11.2.1 Global Cellular and Gene Therapy CDMO Sales (K Units) Forecast by Application
11.2.2 Global Cellular and Gene Therapy CDMO Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cellular and Gene Therapy CDMO
1.2 Key Market Segments
1.2.1 Cellular and Gene Therapy CDMO Segment by Type
1.2.2 Cellular and Gene Therapy CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELLULAR AND GENE THERAPY CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cellular and Gene Therapy CDMO Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cellular and Gene Therapy CDMO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELLULAR AND GENE THERAPY CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Global Cellular and Gene Therapy CDMO Sales by Manufacturers (2019-2024)
3.2 Global Cellular and Gene Therapy CDMO Revenue Market Share by Manufacturers (2019-2024)
3.3 Cellular and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cellular and Gene Therapy CDMO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cellular and Gene Therapy CDMO Sales Sites, Area Served, Product Type
3.6 Cellular and Gene Therapy CDMO Market Competitive Situation and Trends
3.6.1 Cellular and Gene Therapy CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cellular and Gene Therapy CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELLULAR AND GENE THERAPY CDMO INDUSTRY CHAIN ANALYSIS
4.1 Cellular and Gene Therapy CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELLULAR AND GENE THERAPY CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CELLULAR AND GENE THERAPY CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cellular and Gene Therapy CDMO Sales Market Share by Type (2019-2024)
6.3 Global Cellular and Gene Therapy CDMO Market Size Market Share by Type (2019-2024)
6.4 Global Cellular and Gene Therapy CDMO Price by Type (2019-2024)
7 CELLULAR AND GENE THERAPY CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cellular and Gene Therapy CDMO Market Sales by Application (2019-2024)
7.3 Global Cellular and Gene Therapy CDMO Market Size (M USD) by Application (2019-2024)
7.4 Global Cellular and Gene Therapy CDMO Sales Growth Rate by Application (2019-2024)
8 CELLULAR AND GENE THERAPY CDMO MARKET SEGMENTATION BY REGION
8.1 Global Cellular and Gene Therapy CDMO Sales by Region
8.1.1 Global Cellular and Gene Therapy CDMO Sales by Region
8.1.2 Global Cellular and Gene Therapy CDMO Sales Market Share by Region
8.2 North America
8.2.1 North America Cellular and Gene Therapy CDMO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cellular and Gene Therapy CDMO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cellular and Gene Therapy CDMO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cellular and Gene Therapy CDMO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cellular and Gene Therapy CDMO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Catalent
9.1.1 Catalent Cellular and Gene Therapy CDMO Basic Information
9.1.2 Catalent Cellular and Gene Therapy CDMO Product Overview
9.1.3 Catalent Cellular and Gene Therapy CDMO Product Market Performance
9.1.4 Catalent Business Overview
9.1.5 Catalent Cellular and Gene Therapy CDMO SWOT Analysis
9.1.6 Catalent Recent Developments
9.2 Lonza
9.2.1 Lonza Cellular and Gene Therapy CDMO Basic Information
9.2.2 Lonza Cellular and Gene Therapy CDMO Product Overview
9.2.3 Lonza Cellular and Gene Therapy CDMO Product Market Performance
9.2.4 Lonza Business Overview
9.2.5 Lonza Cellular and Gene Therapy CDMO SWOT Analysis
9.2.6 Lonza Recent Developments
9.3 Charles River
9.3.1 Charles River Cellular and Gene Therapy CDMO Basic Information
9.3.2 Charles River Cellular and Gene Therapy CDMO Product Overview
9.3.3 Charles River Cellular and Gene Therapy CDMO Product Market Performance
9.3.4 Charles River Cellular and Gene Therapy CDMO SWOT Analysis
9.3.5 Charles River Business Overview
9.3.6 Charles River Recent Developments
9.4 The Discovery Labs
9.4.1 The Discovery Labs Cellular and Gene Therapy CDMO Basic Information
9.4.2 The Discovery Labs Cellular and Gene Therapy CDMO Product Overview
9.4.3 The Discovery Labs Cellular and Gene Therapy CDMO Product Market Performance
9.4.4 The Discovery Labs Business Overview
9.4.5 The Discovery Labs Recent Developments
9.5 BIOCENTRIQ
9.5.1 BIOCENTRIQ Cellular and Gene Therapy CDMO Basic Information
9.5.2 BIOCENTRIQ Cellular and Gene Therapy CDMO Product Overview
9.5.3 BIOCENTRIQ Cellular and Gene Therapy CDMO Product Market Performance
9.5.4 BIOCENTRIQ Business Overview
9.5.5 BIOCENTRIQ Recent Developments
9.6 FUJIFILM Diosynth Biotechnologies
9.6.1 FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Basic Information
9.6.2 FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Product Overview
9.6.3 FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Product Market Performance
9.6.4 FUJIFILM Diosynth Biotechnologies Business Overview
9.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments
9.7 Exothera
9.7.1 Exothera Cellular and Gene Therapy CDMO Basic Information
9.7.2 Exothera Cellular and Gene Therapy CDMO Product Overview
9.7.3 Exothera Cellular and Gene Therapy CDMO Product Market Performance
9.7.4 Exothera Business Overview
9.7.5 Exothera Recent Developments
9.8 WuXi AppTec
9.8.1 WuXi AppTec Cellular and Gene Therapy CDMO Basic Information
9.8.2 WuXi AppTec Cellular and Gene Therapy CDMO Product Overview
9.8.3 WuXi AppTec Cellular and Gene Therapy CDMO Product Market Performance
9.8.4 WuXi AppTec Business Overview
9.8.5 WuXi AppTec Recent Developments
9.9 Pharmaron
9.9.1 Pharmaron Cellular and Gene Therapy CDMO Basic Information
9.9.2 Pharmaron Cellular and Gene Therapy CDMO Product Overview
9.9.3 Pharmaron Cellular and Gene Therapy CDMO Product Market Performance
9.9.4 Pharmaron Business Overview
9.9.5 Pharmaron Recent Developments
9.10 OBiO
9.10.1 OBiO Cellular and Gene Therapy CDMO Basic Information
9.10.2 OBiO Cellular and Gene Therapy CDMO Product Overview
9.10.3 OBiO Cellular and Gene Therapy CDMO Product Market Performance
9.10.4 OBiO Business Overview
9.10.5 OBiO Recent Developments
9.11 Cell Therapies
9.11.1 Cell Therapies Cellular and Gene Therapy CDMO Basic Information
9.11.2 Cell Therapies Cellular and Gene Therapy CDMO Product Overview
9.11.3 Cell Therapies Cellular and Gene Therapy CDMO Product Market Performance
9.11.4 Cell Therapies Business Overview
9.11.5 Cell Therapies Recent Developments
9.12 AGC Biologics
9.12.1 AGC Biologics Cellular and Gene Therapy CDMO Basic Information
9.12.2 AGC Biologics Cellular and Gene Therapy CDMO Product Overview
9.12.3 AGC Biologics Cellular and Gene Therapy CDMO Product Market Performance
9.12.4 AGC Biologics Business Overview
9.12.5 AGC Biologics Recent Developments
9.13 Cytiva
9.13.1 Cytiva Cellular and Gene Therapy CDMO Basic Information
9.13.2 Cytiva Cellular and Gene Therapy CDMO Product Overview
9.13.3 Cytiva Cellular and Gene Therapy CDMO Product Market Performance
9.13.4 Cytiva Business Overview
9.13.5 Cytiva Recent Developments
9.14 Helixmith
9.14.1 Helixmith Cellular and Gene Therapy CDMO Basic Information
9.14.2 Helixmith Cellular and Gene Therapy CDMO Product Overview
9.14.3 Helixmith Cellular and Gene Therapy CDMO Product Market Performance
9.14.4 Helixmith Business Overview
9.14.5 Helixmith Recent Developments
9.15 ThermoGenesis
9.15.1 ThermoGenesis Cellular and Gene Therapy CDMO Basic Information
9.15.2 ThermoGenesis Cellular and Gene Therapy CDMO Product Overview
9.15.3 ThermoGenesis Cellular and Gene Therapy CDMO Product Market Performance
9.15.4 ThermoGenesis Business Overview
9.15.5 ThermoGenesis Recent Developments
9.16 Anemocyte
9.16.1 Anemocyte Cellular and Gene Therapy CDMO Basic Information
9.16.2 Anemocyte Cellular and Gene Therapy CDMO Product Overview
9.16.3 Anemocyte Cellular and Gene Therapy CDMO Product Market Performance
9.16.4 Anemocyte Business Overview
9.16.5 Anemocyte Recent Developments
9.17 Thermo Fisher Scientific
9.17.1 Thermo Fisher Scientific Cellular and Gene Therapy CDMO Basic Information
9.17.2 Thermo Fisher Scientific Cellular and Gene Therapy CDMO Product Overview
9.17.3 Thermo Fisher Scientific Cellular and Gene Therapy CDMO Product Market Performance
9.17.4 Thermo Fisher Scientific Business Overview
9.17.5 Thermo Fisher Scientific Recent Developments
9.18 CBM
9.18.1 CBM Cellular and Gene Therapy CDMO Basic Information
9.18.2 CBM Cellular and Gene Therapy CDMO Product Overview
9.18.3 CBM Cellular and Gene Therapy CDMO Product Market Performance
9.18.4 CBM Business Overview
9.18.5 CBM Recent Developments
9.19 Bio Elpida
9.19.1 Bio Elpida Cellular and Gene Therapy CDMO Basic Information
9.19.2 Bio Elpida Cellular and Gene Therapy CDMO Product Overview
9.19.3 Bio Elpida Cellular and Gene Therapy CDMO Product Market Performance
9.19.4 Bio Elpida Business Overview
9.19.5 Bio Elpida Recent Developments
9.20 Genezen
9.20.1 Genezen Cellular and Gene Therapy CDMO Basic Information
9.20.2 Genezen Cellular and Gene Therapy CDMO Product Overview
9.20.3 Genezen Cellular and Gene Therapy CDMO Product Market Performance
9.20.4 Genezen Business Overview
9.20.5 Genezen Recent Developments
9.21 CCRM
9.21.1 CCRM Cellular and Gene Therapy CDMO Basic Information
9.21.2 CCRM Cellular and Gene Therapy CDMO Product Overview
9.21.3 CCRM Cellular and Gene Therapy CDMO Product Market Performance
9.21.4 CCRM Business Overview
9.21.5 CCRM Recent Developments
9.22 RoslinCT
9.22.1 RoslinCT Cellular and Gene Therapy CDMO Basic Information
9.22.2 RoslinCT Cellular and Gene Therapy CDMO Product Overview
9.22.3 RoslinCT Cellular and Gene Therapy CDMO Product Market Performance
9.22.4 RoslinCT Business Overview
9.22.5 RoslinCT Recent Developments
9.23 GenScript ProBio
9.23.1 GenScript ProBio Cellular and Gene Therapy CDMO Basic Information
9.23.2 GenScript ProBio Cellular and Gene Therapy CDMO Product Overview
9.23.3 GenScript ProBio Cellular and Gene Therapy CDMO Product Market Performance
9.23.4 GenScript ProBio Business Overview
9.23.5 GenScript ProBio Recent Developments
9.24 Oxford BioMedica
9.24.1 Oxford BioMedica Cellular and Gene Therapy CDMO Basic Information
9.24.2 Oxford BioMedica Cellular and Gene Therapy CDMO Product Overview
9.24.3 Oxford BioMedica Cellular and Gene Therapy CDMO Product Market Performance
9.24.4 Oxford BioMedica Business Overview
9.24.5 Oxford BioMedica Recent Developments
9.25 Porton Pharma Solutions
9.25.1 Porton Pharma Solutions Cellular and Gene Therapy CDMO Basic Information
9.25.2 Porton Pharma Solutions Cellular and Gene Therapy CDMO Product Overview
9.25.3 Porton Pharma Solutions Cellular and Gene Therapy CDMO Product Market Performance
9.25.4 Porton Pharma Solutions Business Overview
9.25.5 Porton Pharma Solutions Recent Developments
10 CELLULAR AND GENE THERAPY CDMO MARKET FORECAST BY REGION
10.1 Global Cellular and Gene Therapy CDMO Market Size Forecast
10.2 Global Cellular and Gene Therapy CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cellular and Gene Therapy CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Cellular and Gene Therapy CDMO Market Size Forecast by Region
10.2.4 South America Cellular and Gene Therapy CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cellular and Gene Therapy CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Cellular and Gene Therapy CDMO Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cellular and Gene Therapy CDMO by Type (2025-2030)
11.1.2 Global Cellular and Gene Therapy CDMO Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cellular and Gene Therapy CDMO by Type (2025-2030)
11.2 Global Cellular and Gene Therapy CDMO Market Forecast by Application (2025-2030)
11.2.1 Global Cellular and Gene Therapy CDMO Sales (K Units) Forecast by Application
11.2.2 Global Cellular and Gene Therapy CDMO Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cellular and Gene Therapy CDMO Market Size Comparison by Region (M USD)
Table 5. Global Cellular and Gene Therapy CDMO Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cellular and Gene Therapy CDMO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cellular and Gene Therapy CDMO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cellular and Gene Therapy CDMO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular and Gene Therapy CDMO as of 2022)
Table 10. Global Market Cellular and Gene Therapy CDMO Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cellular and Gene Therapy CDMO Sales Sites and Area Served
Table 12. Manufacturers Cellular and Gene Therapy CDMO Product Type
Table 13. Global Cellular and Gene Therapy CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cellular and Gene Therapy CDMO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cellular and Gene Therapy CDMO Market Challenges
Table 22. Global Cellular and Gene Therapy CDMO Sales by Type (K Units)
Table 23. Global Cellular and Gene Therapy CDMO Market Size by Type (M USD)
Table 24. Global Cellular and Gene Therapy CDMO Sales (K Units) by Type (2019-2024)
Table 25. Global Cellular and Gene Therapy CDMO Sales Market Share by Type (2019-2024)
Table 26. Global Cellular and Gene Therapy CDMO Market Size (M USD) by Type (2019-2024)
Table 27. Global Cellular and Gene Therapy CDMO Market Size Share by Type (2019-2024)
Table 28. Global Cellular and Gene Therapy CDMO Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cellular and Gene Therapy CDMO Sales (K Units) by Application
Table 30. Global Cellular and Gene Therapy CDMO Market Size by Application
Table 31. Global Cellular and Gene Therapy CDMO Sales by Application (2019-2024) & (K Units)
Table 32. Global Cellular and Gene Therapy CDMO Sales Market Share by Application (2019-2024)
Table 33. Global Cellular and Gene Therapy CDMO Sales by Application (2019-2024) & (M USD)
Table 34. Global Cellular and Gene Therapy CDMO Market Share by Application (2019-2024)
Table 35. Global Cellular and Gene Therapy CDMO Sales Growth Rate by Application (2019-2024)
Table 36. Global Cellular and Gene Therapy CDMO Sales by Region (2019-2024) & (K Units)
Table 37. Global Cellular and Gene Therapy CDMO Sales Market Share by Region (2019-2024)
Table 38. North America Cellular and Gene Therapy CDMO Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cellular and Gene Therapy CDMO Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cellular and Gene Therapy CDMO Sales by Region (2019-2024) & (K Units)
Table 41. South America Cellular and Gene Therapy CDMO Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cellular and Gene Therapy CDMO Sales by Region (2019-2024) & (K Units)
Table 43. Catalent Cellular and Gene Therapy CDMO Basic Information
Table 44. Catalent Cellular and Gene Therapy CDMO Product Overview
Table 45. Catalent Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Catalent Business Overview
Table 47. Catalent Cellular and Gene Therapy CDMO SWOT Analysis
Table 48. Catalent Recent Developments
Table 49. Lonza Cellular and Gene Therapy CDMO Basic Information
Table 50. Lonza Cellular and Gene Therapy CDMO Product Overview
Table 51. Lonza Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Lonza Business Overview
Table 53. Lonza Cellular and Gene Therapy CDMO SWOT Analysis
Table 54. Lonza Recent Developments
Table 55. Charles River Cellular and Gene Therapy CDMO Basic Information
Table 56. Charles River Cellular and Gene Therapy CDMO Product Overview
Table 57. Charles River Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Charles River Cellular and Gene Therapy CDMO SWOT Analysis
Table 59. Charles River Business Overview
Table 60. Charles River Recent Developments
Table 61. The Discovery Labs Cellular and Gene Therapy CDMO Basic Information
Table 62. The Discovery Labs Cellular and Gene Therapy CDMO Product Overview
Table 63. The Discovery Labs Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. The Discovery Labs Business Overview
Table 65. The Discovery Labs Recent Developments
Table 66. BIOCENTRIQ Cellular and Gene Therapy CDMO Basic Information
Table 67. BIOCENTRIQ Cellular and Gene Therapy CDMO Product Overview
Table 68. BIOCENTRIQ Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. BIOCENTRIQ Business Overview
Table 70. BIOCENTRIQ Recent Developments
Table 71. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Basic Information
Table 72. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Product Overview
Table 73. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. FUJIFILM Diosynth Biotechnologies Business Overview
Table 75. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 76. Exothera Cellular and Gene Therapy CDMO Basic Information
Table 77. Exothera Cellular and Gene Therapy CDMO Product Overview
Table 78. Exothera Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Exothera Business Overview
Table 80. Exothera Recent Developments
Table 81. WuXi AppTec Cellular and Gene Therapy CDMO Basic Information
Table 82. WuXi AppTec Cellular and Gene Therapy CDMO Product Overview
Table 83. WuXi AppTec Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. WuXi AppTec Business Overview
Table 85. WuXi AppTec Recent Developments
Table 86. Pharmaron Cellular and Gene Therapy CDMO Basic Information
Table 87. Pharmaron Cellular and Gene Therapy CDMO Product Overview
Table 88. Pharmaron Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Pharmaron Business Overview
Table 90. Pharmaron Recent Developments
Table 91. OBiO Cellular and Gene Therapy CDMO Basic Information
Table 92. OBiO Cellular and Gene Therapy CDMO Product Overview
Table 93. OBiO Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. OBiO Business Overview
Table 95. OBiO Recent Developments
Table 96. Cell Therapies Cellular and Gene Therapy CDMO Basic Information
Table 97. Cell Therapies Cellular and Gene Therapy CDMO Product Overview
Table 98. Cell Therapies Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Cell Therapies Business Overview
Table 100. Cell Therapies Recent Developments
Table 101. AGC Biologics Cellular and Gene Therapy CDMO Basic Information
Table 102. AGC Biologics Cellular and Gene Therapy CDMO Product Overview
Table 103. AGC Biologics Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. AGC Biologics Business Overview
Table 105. AGC Biologics Recent Developments
Table 106. Cytiva Cellular and Gene Therapy CDMO Basic Information
Table 107. Cytiva Cellular and Gene Therapy CDMO Product Overview
Table 108. Cytiva Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Cytiva Business Overview
Table 110. Cytiva Recent Developments
Table 111. Helixmith Cellular and Gene Therapy CDMO Basic Information
Table 112. Helixmith Cellular and Gene Therapy CDMO Product Overview
Table 113. Helixmith Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Helixmith Business Overview
Table 115. Helixmith Recent Developments
Table 116. ThermoGenesis Cellular and Gene Therapy CDMO Basic Information
Table 117. ThermoGenesis Cellular and Gene Therapy CDMO Product Overview
Table 118. ThermoGenesis Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. ThermoGenesis Business Overview
Table 120. ThermoGenesis Recent Developments
Table 121. Anemocyte Cellular and Gene Therapy CDMO Basic Information
Table 122. Anemocyte Cellular and Gene Therapy CDMO Product Overview
Table 123. Anemocyte Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Anemocyte Business Overview
Table 125. Anemocyte Recent Developments
Table 126. Thermo Fisher Scientific Cellular and Gene Therapy CDMO Basic Information
Table 127. Thermo Fisher Scientific Cellular and Gene Therapy CDMO Product Overview
Table 128. Thermo Fisher Scientific Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Thermo Fisher Scientific Business Overview
Table 130. Thermo Fisher Scientific Recent Developments
Table 131. CBM Cellular and Gene Therapy CDMO Basic Information
Table 132. CBM Cellular and Gene Therapy CDMO Product Overview
Table 133. CBM Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. CBM Business Overview
Table 135. CBM Recent Developments
Table 136. Bio Elpida Cellular and Gene Therapy CDMO Basic Information
Table 137. Bio Elpida Cellular and Gene Therapy CDMO Product Overview
Table 138. Bio Elpida Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Bio Elpida Business Overview
Table 140. Bio Elpida Recent Developments
Table 141. Genezen Cellular and Gene Therapy CDMO Basic Information
Table 142. Genezen Cellular and Gene Therapy CDMO Product Overview
Table 143. Genezen Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Genezen Business Overview
Table 145. Genezen Recent Developments
Table 146. CCRM Cellular and Gene Therapy CDMO Basic Information
Table 147. CCRM Cellular and Gene Therapy CDMO Product Overview
Table 148. CCRM Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. CCRM Business Overview
Table 150. CCRM Recent Developments
Table 151. RoslinCT Cellular and Gene Therapy CDMO Basic Information
Table 152. RoslinCT Cellular and Gene Therapy CDMO Product Overview
Table 153. RoslinCT Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. RoslinCT Business Overview
Table 155. RoslinCT Recent Developments
Table 156. GenScript ProBio Cellular and Gene Therapy CDMO Basic Information
Table 157. GenScript ProBio Cellular and Gene Therapy CDMO Product Overview
Table 158. GenScript ProBio Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. GenScript ProBio Business Overview
Table 160. GenScript ProBio Recent Developments
Table 161. Oxford BioMedica Cellular and Gene Therapy CDMO Basic Information
Table 162. Oxford BioMedica Cellular and Gene Therapy CDMO Product Overview
Table 163. Oxford BioMedica Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 164. Oxford BioMedica Business Overview
Table 165. Oxford BioMedica Recent Developments
Table 166. Porton Pharma Solutions Cellular and Gene Therapy CDMO Basic Information
Table 167. Porton Pharma Solutions Cellular and Gene Therapy CDMO Product Overview
Table 168. Porton Pharma Solutions Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 169. Porton Pharma Solutions Business Overview
Table 170. Porton Pharma Solutions Recent Developments
Table 171. Global Cellular and Gene Therapy CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 172. Global Cellular and Gene Therapy CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 173. North America Cellular and Gene Therapy CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 174. North America Cellular and Gene Therapy CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 175. Europe Cellular and Gene Therapy CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 176. Europe Cellular and Gene Therapy CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 177. Asia Pacific Cellular and Gene Therapy CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 178. Asia Pacific Cellular and Gene Therapy CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 179. South America Cellular and Gene Therapy CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 180. South America Cellular and Gene Therapy CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 181. Middle East and Africa Cellular and Gene Therapy CDMO Consumption Forecast by Country (2025-2030) & (Units)
Table 182. Middle East and Africa Cellular and Gene Therapy CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 183. Global Cellular and Gene Therapy CDMO Sales Forecast by Type (2025-2030) & (K Units)
Table 184. Global Cellular and Gene Therapy CDMO Market Size Forecast by Type (2025-2030) & (M USD)
Table 185. Global Cellular and Gene Therapy CDMO Price Forecast by Type (2025-2030) & (USD/Unit)
Table 186. Global Cellular and Gene Therapy CDMO Sales (K Units) Forecast by Application (2025-2030)
Table 187. Global Cellular and Gene Therapy CDMO Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cellular and Gene Therapy CDMO Market Size Comparison by Region (M USD)
Table 5. Global Cellular and Gene Therapy CDMO Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cellular and Gene Therapy CDMO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cellular and Gene Therapy CDMO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cellular and Gene Therapy CDMO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular and Gene Therapy CDMO as of 2022)
Table 10. Global Market Cellular and Gene Therapy CDMO Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cellular and Gene Therapy CDMO Sales Sites and Area Served
Table 12. Manufacturers Cellular and Gene Therapy CDMO Product Type
Table 13. Global Cellular and Gene Therapy CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cellular and Gene Therapy CDMO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cellular and Gene Therapy CDMO Market Challenges
Table 22. Global Cellular and Gene Therapy CDMO Sales by Type (K Units)
Table 23. Global Cellular and Gene Therapy CDMO Market Size by Type (M USD)
Table 24. Global Cellular and Gene Therapy CDMO Sales (K Units) by Type (2019-2024)
Table 25. Global Cellular and Gene Therapy CDMO Sales Market Share by Type (2019-2024)
Table 26. Global Cellular and Gene Therapy CDMO Market Size (M USD) by Type (2019-2024)
Table 27. Global Cellular and Gene Therapy CDMO Market Size Share by Type (2019-2024)
Table 28. Global Cellular and Gene Therapy CDMO Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cellular and Gene Therapy CDMO Sales (K Units) by Application
Table 30. Global Cellular and Gene Therapy CDMO Market Size by Application
Table 31. Global Cellular and Gene Therapy CDMO Sales by Application (2019-2024) & (K Units)
Table 32. Global Cellular and Gene Therapy CDMO Sales Market Share by Application (2019-2024)
Table 33. Global Cellular and Gene Therapy CDMO Sales by Application (2019-2024) & (M USD)
Table 34. Global Cellular and Gene Therapy CDMO Market Share by Application (2019-2024)
Table 35. Global Cellular and Gene Therapy CDMO Sales Growth Rate by Application (2019-2024)
Table 36. Global Cellular and Gene Therapy CDMO Sales by Region (2019-2024) & (K Units)
Table 37. Global Cellular and Gene Therapy CDMO Sales Market Share by Region (2019-2024)
Table 38. North America Cellular and Gene Therapy CDMO Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cellular and Gene Therapy CDMO Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cellular and Gene Therapy CDMO Sales by Region (2019-2024) & (K Units)
Table 41. South America Cellular and Gene Therapy CDMO Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cellular and Gene Therapy CDMO Sales by Region (2019-2024) & (K Units)
Table 43. Catalent Cellular and Gene Therapy CDMO Basic Information
Table 44. Catalent Cellular and Gene Therapy CDMO Product Overview
Table 45. Catalent Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Catalent Business Overview
Table 47. Catalent Cellular and Gene Therapy CDMO SWOT Analysis
Table 48. Catalent Recent Developments
Table 49. Lonza Cellular and Gene Therapy CDMO Basic Information
Table 50. Lonza Cellular and Gene Therapy CDMO Product Overview
Table 51. Lonza Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Lonza Business Overview
Table 53. Lonza Cellular and Gene Therapy CDMO SWOT Analysis
Table 54. Lonza Recent Developments
Table 55. Charles River Cellular and Gene Therapy CDMO Basic Information
Table 56. Charles River Cellular and Gene Therapy CDMO Product Overview
Table 57. Charles River Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Charles River Cellular and Gene Therapy CDMO SWOT Analysis
Table 59. Charles River Business Overview
Table 60. Charles River Recent Developments
Table 61. The Discovery Labs Cellular and Gene Therapy CDMO Basic Information
Table 62. The Discovery Labs Cellular and Gene Therapy CDMO Product Overview
Table 63. The Discovery Labs Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. The Discovery Labs Business Overview
Table 65. The Discovery Labs Recent Developments
Table 66. BIOCENTRIQ Cellular and Gene Therapy CDMO Basic Information
Table 67. BIOCENTRIQ Cellular and Gene Therapy CDMO Product Overview
Table 68. BIOCENTRIQ Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. BIOCENTRIQ Business Overview
Table 70. BIOCENTRIQ Recent Developments
Table 71. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Basic Information
Table 72. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Product Overview
Table 73. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. FUJIFILM Diosynth Biotechnologies Business Overview
Table 75. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 76. Exothera Cellular and Gene Therapy CDMO Basic Information
Table 77. Exothera Cellular and Gene Therapy CDMO Product Overview
Table 78. Exothera Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Exothera Business Overview
Table 80. Exothera Recent Developments
Table 81. WuXi AppTec Cellular and Gene Therapy CDMO Basic Information
Table 82. WuXi AppTec Cellular and Gene Therapy CDMO Product Overview
Table 83. WuXi AppTec Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. WuXi AppTec Business Overview
Table 85. WuXi AppTec Recent Developments
Table 86. Pharmaron Cellular and Gene Therapy CDMO Basic Information
Table 87. Pharmaron Cellular and Gene Therapy CDMO Product Overview
Table 88. Pharmaron Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Pharmaron Business Overview
Table 90. Pharmaron Recent Developments
Table 91. OBiO Cellular and Gene Therapy CDMO Basic Information
Table 92. OBiO Cellular and Gene Therapy CDMO Product Overview
Table 93. OBiO Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. OBiO Business Overview
Table 95. OBiO Recent Developments
Table 96. Cell Therapies Cellular and Gene Therapy CDMO Basic Information
Table 97. Cell Therapies Cellular and Gene Therapy CDMO Product Overview
Table 98. Cell Therapies Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Cell Therapies Business Overview
Table 100. Cell Therapies Recent Developments
Table 101. AGC Biologics Cellular and Gene Therapy CDMO Basic Information
Table 102. AGC Biologics Cellular and Gene Therapy CDMO Product Overview
Table 103. AGC Biologics Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. AGC Biologics Business Overview
Table 105. AGC Biologics Recent Developments
Table 106. Cytiva Cellular and Gene Therapy CDMO Basic Information
Table 107. Cytiva Cellular and Gene Therapy CDMO Product Overview
Table 108. Cytiva Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Cytiva Business Overview
Table 110. Cytiva Recent Developments
Table 111. Helixmith Cellular and Gene Therapy CDMO Basic Information
Table 112. Helixmith Cellular and Gene Therapy CDMO Product Overview
Table 113. Helixmith Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Helixmith Business Overview
Table 115. Helixmith Recent Developments
Table 116. ThermoGenesis Cellular and Gene Therapy CDMO Basic Information
Table 117. ThermoGenesis Cellular and Gene Therapy CDMO Product Overview
Table 118. ThermoGenesis Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. ThermoGenesis Business Overview
Table 120. ThermoGenesis Recent Developments
Table 121. Anemocyte Cellular and Gene Therapy CDMO Basic Information
Table 122. Anemocyte Cellular and Gene Therapy CDMO Product Overview
Table 123. Anemocyte Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Anemocyte Business Overview
Table 125. Anemocyte Recent Developments
Table 126. Thermo Fisher Scientific Cellular and Gene Therapy CDMO Basic Information
Table 127. Thermo Fisher Scientific Cellular and Gene Therapy CDMO Product Overview
Table 128. Thermo Fisher Scientific Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Thermo Fisher Scientific Business Overview
Table 130. Thermo Fisher Scientific Recent Developments
Table 131. CBM Cellular and Gene Therapy CDMO Basic Information
Table 132. CBM Cellular and Gene Therapy CDMO Product Overview
Table 133. CBM Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. CBM Business Overview
Table 135. CBM Recent Developments
Table 136. Bio Elpida Cellular and Gene Therapy CDMO Basic Information
Table 137. Bio Elpida Cellular and Gene Therapy CDMO Product Overview
Table 138. Bio Elpida Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Bio Elpida Business Overview
Table 140. Bio Elpida Recent Developments
Table 141. Genezen Cellular and Gene Therapy CDMO Basic Information
Table 142. Genezen Cellular and Gene Therapy CDMO Product Overview
Table 143. Genezen Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Genezen Business Overview
Table 145. Genezen Recent Developments
Table 146. CCRM Cellular and Gene Therapy CDMO Basic Information
Table 147. CCRM Cellular and Gene Therapy CDMO Product Overview
Table 148. CCRM Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. CCRM Business Overview
Table 150. CCRM Recent Developments
Table 151. RoslinCT Cellular and Gene Therapy CDMO Basic Information
Table 152. RoslinCT Cellular and Gene Therapy CDMO Product Overview
Table 153. RoslinCT Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. RoslinCT Business Overview
Table 155. RoslinCT Recent Developments
Table 156. GenScript ProBio Cellular and Gene Therapy CDMO Basic Information
Table 157. GenScript ProBio Cellular and Gene Therapy CDMO Product Overview
Table 158. GenScript ProBio Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. GenScript ProBio Business Overview
Table 160. GenScript ProBio Recent Developments
Table 161. Oxford BioMedica Cellular and Gene Therapy CDMO Basic Information
Table 162. Oxford BioMedica Cellular and Gene Therapy CDMO Product Overview
Table 163. Oxford BioMedica Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 164. Oxford BioMedica Business Overview
Table 165. Oxford BioMedica Recent Developments
Table 166. Porton Pharma Solutions Cellular and Gene Therapy CDMO Basic Information
Table 167. Porton Pharma Solutions Cellular and Gene Therapy CDMO Product Overview
Table 168. Porton Pharma Solutions Cellular and Gene Therapy CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 169. Porton Pharma Solutions Business Overview
Table 170. Porton Pharma Solutions Recent Developments
Table 171. Global Cellular and Gene Therapy CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 172. Global Cellular and Gene Therapy CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 173. North America Cellular and Gene Therapy CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 174. North America Cellular and Gene Therapy CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 175. Europe Cellular and Gene Therapy CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 176. Europe Cellular and Gene Therapy CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 177. Asia Pacific Cellular and Gene Therapy CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 178. Asia Pacific Cellular and Gene Therapy CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 179. South America Cellular and Gene Therapy CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 180. South America Cellular and Gene Therapy CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 181. Middle East and Africa Cellular and Gene Therapy CDMO Consumption Forecast by Country (2025-2030) & (Units)
Table 182. Middle East and Africa Cellular and Gene Therapy CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 183. Global Cellular and Gene Therapy CDMO Sales Forecast by Type (2025-2030) & (K Units)
Table 184. Global Cellular and Gene Therapy CDMO Market Size Forecast by Type (2025-2030) & (M USD)
Table 185. Global Cellular and Gene Therapy CDMO Price Forecast by Type (2025-2030) & (USD/Unit)
Table 186. Global Cellular and Gene Therapy CDMO Sales (K Units) Forecast by Application (2025-2030)
Table 187. Global Cellular and Gene Therapy CDMO Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Cellular and Gene Therapy CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cellular and Gene Therapy CDMO Market Size (M USD), 2019-2030
Figure 5. Global Cellular and Gene Therapy CDMO Market Size (M USD) (2019-2030)
Figure 6. Global Cellular and Gene Therapy CDMO Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cellular and Gene Therapy CDMO Market Size by Country (M USD)
Figure 11. Cellular and Gene Therapy CDMO Sales Share by Manufacturers in 2023
Figure 12. Global Cellular and Gene Therapy CDMO Revenue Share by Manufacturers in 2023
Figure 13. Cellular and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cellular and Gene Therapy CDMO Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cellular and Gene Therapy CDMO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cellular and Gene Therapy CDMO Market Share by Type
Figure 18. Sales Market Share of Cellular and Gene Therapy CDMO by Type (2019-2024)
Figure 19. Sales Market Share of Cellular and Gene Therapy CDMO by Type in 2023
Figure 20. Market Size Share of Cellular and Gene Therapy CDMO by Type (2019-2024)
Figure 21. Market Size Market Share of Cellular and Gene Therapy CDMO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cellular and Gene Therapy CDMO Market Share by Application
Figure 24. Global Cellular and Gene Therapy CDMO Sales Market Share by Application (2019-2024)
Figure 25. Global Cellular and Gene Therapy CDMO Sales Market Share by Application in 2023
Figure 26. Global Cellular and Gene Therapy CDMO Market Share by Application (2019-2024)
Figure 27. Global Cellular and Gene Therapy CDMO Market Share by Application in 2023
Figure 28. Global Cellular and Gene Therapy CDMO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cellular and Gene Therapy CDMO Sales Market Share by Region (2019-2024)
Figure 30. North America Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cellular and Gene Therapy CDMO Sales Market Share by Country in 2023
Figure 32. U.S. Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cellular and Gene Therapy CDMO Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cellular and Gene Therapy CDMO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cellular and Gene Therapy CDMO Sales Market Share by Country in 2023
Figure 37. Germany Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cellular and Gene Therapy CDMO Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cellular and Gene Therapy CDMO Sales Market Share by Region in 2023
Figure 44. China Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cellular and Gene Therapy CDMO Sales and Growth Rate (K Units)
Figure 50. South America Cellular and Gene Therapy CDMO Sales Market Share by Country in 2023
Figure 51. Brazil Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cellular and Gene Therapy CDMO Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cellular and Gene Therapy CDMO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cellular and Gene Therapy CDMO Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Cellular and Gene Therapy CDMO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Cellular and Gene Therapy CDMO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Cellular and Gene Therapy CDMO Market Share Forecast by Type (2025-2030)
Figure 65. Global Cellular and Gene Therapy CDMO Sales Forecast by Application (2025-2030)
Figure 66. Global Cellular and Gene Therapy CDMO Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Cellular and Gene Therapy CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cellular and Gene Therapy CDMO Market Size (M USD), 2019-2030
Figure 5. Global Cellular and Gene Therapy CDMO Market Size (M USD) (2019-2030)
Figure 6. Global Cellular and Gene Therapy CDMO Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cellular and Gene Therapy CDMO Market Size by Country (M USD)
Figure 11. Cellular and Gene Therapy CDMO Sales Share by Manufacturers in 2023
Figure 12. Global Cellular and Gene Therapy CDMO Revenue Share by Manufacturers in 2023
Figure 13. Cellular and Gene Therapy CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cellular and Gene Therapy CDMO Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cellular and Gene Therapy CDMO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cellular and Gene Therapy CDMO Market Share by Type
Figure 18. Sales Market Share of Cellular and Gene Therapy CDMO by Type (2019-2024)
Figure 19. Sales Market Share of Cellular and Gene Therapy CDMO by Type in 2023
Figure 20. Market Size Share of Cellular and Gene Therapy CDMO by Type (2019-2024)
Figure 21. Market Size Market Share of Cellular and Gene Therapy CDMO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cellular and Gene Therapy CDMO Market Share by Application
Figure 24. Global Cellular and Gene Therapy CDMO Sales Market Share by Application (2019-2024)
Figure 25. Global Cellular and Gene Therapy CDMO Sales Market Share by Application in 2023
Figure 26. Global Cellular and Gene Therapy CDMO Market Share by Application (2019-2024)
Figure 27. Global Cellular and Gene Therapy CDMO Market Share by Application in 2023
Figure 28. Global Cellular and Gene Therapy CDMO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cellular and Gene Therapy CDMO Sales Market Share by Region (2019-2024)
Figure 30. North America Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cellular and Gene Therapy CDMO Sales Market Share by Country in 2023
Figure 32. U.S. Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cellular and Gene Therapy CDMO Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cellular and Gene Therapy CDMO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cellular and Gene Therapy CDMO Sales Market Share by Country in 2023
Figure 37. Germany Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cellular and Gene Therapy CDMO Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cellular and Gene Therapy CDMO Sales Market Share by Region in 2023
Figure 44. China Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cellular and Gene Therapy CDMO Sales and Growth Rate (K Units)
Figure 50. South America Cellular and Gene Therapy CDMO Sales Market Share by Country in 2023
Figure 51. Brazil Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cellular and Gene Therapy CDMO Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cellular and Gene Therapy CDMO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cellular and Gene Therapy CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cellular and Gene Therapy CDMO Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Cellular and Gene Therapy CDMO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Cellular and Gene Therapy CDMO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Cellular and Gene Therapy CDMO Market Share Forecast by Type (2025-2030)
Figure 65. Global Cellular and Gene Therapy CDMO Sales Forecast by Application (2025-2030)
Figure 66. Global Cellular and Gene Therapy CDMO Market Share Forecast by Application (2025-2030)
